GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Premier Biomedical Inc (OTCPK:BIEI) » Definitions » Debt-to-Revenue

Premier Biomedical (Premier Biomedical) Debt-to-Revenue : 40.25 (As of Dec. 2019)


View and export this data going back to 2012. Start your Free Trial

What is Premier Biomedical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Premier Biomedical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.16 Mil. Premier Biomedical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.00 Mil. Premier Biomedical's annualized Revenue for the quarter that ended in Dec. 2019 was $0.00 Mil. Premier Biomedical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2019 was 40.25.


Premier Biomedical Debt-to-Revenue Historical Data

The historical data trend for Premier Biomedical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Premier Biomedical Debt-to-Revenue Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only N/A N/A 4.25 7.75 11.50

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.61 10.54 15.63 16.00 40.25

Competitive Comparison of Premier Biomedical's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Premier Biomedical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Premier Biomedical's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Premier Biomedical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's Debt-to-Revenue falls into.



Premier Biomedical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Premier Biomedical's Debt-to-Revenue for the fiscal year that ended in Dec. 2019 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.161 + 0) / 0.014
=11.50

Premier Biomedical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2019 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.161 + 0) / 0.004
=40.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2019) Revenue data.


Premier Biomedical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Premier Biomedical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Premier Biomedical (Premier Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
2409 Sycamore Drive, Knoxville, TN, USA, 37921
Premier Biomedical Inc is engaged in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.